Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma

Clinical trial NCT02050919 · COMPLETED

Trial details

NCT number: NCT02050919
Sponsor: OHSU Knight Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pleomorphic Rhabdomyosarcoma Stage IIB Adult Soft Tissue Sarcoma AJCC v7 Stage III Adult Soft Tissue Sarcoma AJCC v7 Stage IV Adult Soft Tissue Sarcoma AJCC v7

Start date: 2013-12-03
Primary completion: 2018-05-07
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.